会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 54. 发明申请
    • ADIPONECTIN RECEPTOR FRAGMENTS AND METHODS OF USE
    • ADIPONECTIN受体片段和使用方法
    • US20110301089A1
    • 2011-12-08
    • US13211558
    • 2011-08-17
    • Michael J. PugiaRui Ma
    • Michael J. PugiaRui Ma
    • A61K38/17A61P9/00
    • C07K14/72A61K38/00
    • Methods are disclosed of treating diabetes, abnormal adipocyte activity, and insulin resistance using C-terminal fragments of adiponectin receptor R1. Methods of causing the secretion of insulin in healthy and diabetic patients using C-terminal fragments of adiponectin receptor R1 are also disclosed. In addition, methods are disclosed of increasing the insulin levels in healthy patients using C-terminal fragments of adiponectin receptor R1. In addition, methods of treating abnormal adipocyte activity, treating metabolic syndrome, causing insulin secretion, increasing insulin levels, inhibiting insulin degradation enzyme, treating Alzheimer's disease, treating cardiovascular disease associated with adiponectin levels, inhibiting ADAM-17 enzyme, treating a condition associated with TNF-alpha, and treating a condition associated with HER2-neu are disclosed. Compositions, dosage forms, and kits are also disclosed.
    • 公开了使用脂联素受体R1的C末端片段治疗糖尿病,异常脂肪细胞活性和胰岛素抵抗的方法。 还公开了使用脂联素受体R1的C末端片段在健康和糖尿病患者中分泌胰岛素的方法。 此外,公开了使用脂联素受体R1的C末端片段增加健康患者的胰岛素水平的方法。 另外,处理异常脂肪细胞活性,治疗代谢综合征,引起胰岛素分泌,增加胰岛素水平,抑制胰岛素降解酶,治疗阿尔茨海默氏病,治疗与脂联素水平相关的心血管疾病,抑制ADAM-17酶,治疗与 公开了TNF-α和治疗与HER2-neu相关的病症。 还公开了组合物,剂型和试剂盒。
    • 55. 发明授权
    • Adiponectin receptor fragments and methods of use
    • 脂联素受体片段和使用方法
    • US08017573B2
    • 2011-09-13
    • US12169983
    • 2008-07-09
    • Michael J. PugiaRui Ma
    • Michael J. PugiaRui Ma
    • A61K38/17
    • C07K14/72A61K38/00
    • Methods are disclosed of treating diabetes, abnormal adipocyte activity, and insulin resistance using C-terminal fragments of adiponectin receptor R1. Methods of causing the secretion of insulin in healthy and diabetic patients using C-terminal fragments of adiponectin receptor R1 are also disclosed. In addition, methods are disclosed of increasing the insulin levels in healthy patients using C-terminal fragments of adiponectin receptor R1. In addition, methods of treating abnormal adipocyte activity, treating metabolic syndrome, causing insulin secretion, increasing insulin levels, inhibiting insulin degradation enzyme, treating Alzheimer's disease, treating cardiovascular disease associated with adiponectin levels, inhibiting ADAM-17 enzyme, treating a condition associated with TNF-alpha, and treating a condition associated with HER2-neu are disclosed. Compositions, dosage forms, and kits are also disclosed.
    • 公开了使用脂联素受体R1的C末端片段治疗糖尿病,异常脂肪细胞活性和胰岛素抵抗的方法。 还公开了使用脂联素受体R1的C末端片段在健康和糖尿病患者中分泌胰岛素的方法。 此外,公开了使用脂联素受体R1的C末端片段增加健康患者的胰岛素水平的方法。 另外,处理异常脂肪细胞活性,治疗代谢综合征,引起胰岛素分泌,增加胰岛素水平,抑制胰岛素降解酶,治疗阿尔茨海默氏病,治疗与脂联素水平相关的心血管疾病,抑制ADAM-17酶,治疗与 公开了TNF-α和治疗与HER2-neu相关的病症。 还公开了组合物,剂型和试剂盒。